Search Research Articles
Browse Research Categories

TH9507 Peptide Research

Tesamorelin is a synthetic GHRH analog comprising the full 44-amino-acid sequence of human GHRH with a trans-3-hexenoic acid modification that enhances stability and extends its half-life. It has received FDA approval for the treatment of HIV-associated lipodystrophy and is the only GHRH analog with this regulatory status. Research beyond its approved indication has explored its applications in visceral fat reduction, cognitive function improvement in older adults, cardiovascular risk factor modulation, and non-alcoholic fatty liver disease. This section covers scientific studies on Tesamorelin and its GHRH analog, metabolic, and GH axis peptide research applications.

Other Popular Research Categories

Newest TH9507 Research

Tesamorelin Peptide Research – Complete Guide

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates pulsatile growth hormone secretion from the pituitary gland, driving preferential reduction of visceral adipose tissue in research models. It is the only GHRH analog to have completed Phase 3 clinical trials, earning FDA approval in 2010 for HIV-associated lipodystrophy, making it one of the most clinically documented research...

About The Cenexa Labs Research Library

This section of the research library focuses on scientific studies involving and related research. The Cenexa Research Library compiles publicly available scientific literature and research summaries related to peptides, bioregulators, and signaling molecules. Our goal is to make complex scientific research easier to understand without requiring a technical background.
Scroll to Top
0